Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Michael Howland"'
Publikováno v:
Wind Energy, Vol 27, Iss 7, Pp 695-710 (2024)
Abstract Offshore wind turbines have rapidly scaled up in recent years, with plans to construct turbines up to 22 MW in the next decade. However, the operations and maintenance (O&M) requirements for these ‘next‐generation turbines’ remain larg
Externí odkaz:
https://doaj.org/article/0b3329640ea74146805e73b2d9aabb75
Autor:
Yiran Zhang, Kelly Curtis, Lanjia Lin, John Park, Douglas Adkins, A Dimitrios Colevas, Natalie Rainey, Bruno Fang, Minh Phan, Katie Kerrigan, Venessa Chin, Diogo Alpuim Costa, José Dinis, Siu-Chi Chang Sun, Michael Howland
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7aa15cf15277499fba361e2075238edb
Autor:
Anne Conan, Christa A. Gallagher, Nicole Erskine, Michael Howland, Marshalette Smith-Anthony, Silvia Marchi, Ioannis Magouras, Ananda Müller, Anne A.M.J. Becker
Publikováno v:
One Health, Vol 16, Iss , Pp 100485- (2023)
Coxiella burnetii is globally distributed but evidence of zoonotic transmission in the Caribbean region is scarce. The bacterium presence is suspected on the Caribbean island of St. Kitts. The risk of exposure of veterinary students was reported in o
Externí odkaz:
https://doaj.org/article/735f6b0cbe4a4a0183b82ea858f08f72
Publikováno v:
Problems and Perspectives in Management, Vol 11, Iss 4 (2013)
Externí odkaz:
https://doaj.org/article/15d65e5738a5462c826a23b64f8d7eca
Autor:
Natalie Rainey, Rohit Joshi, Joanne Win Yang Chiu, Ann Chen, Hao Wang, Jared Odegard, Michael Howland, Sylvia Adams
Publikováno v:
Cancer Research. 83:OT2-10
Background: Improving outcomes for patients (pts) with triple-negative breast cancer (TNBC) remains a high unmet need. Immune checkpoint inhibitors (ICIs) + chemotherapy (chemo) and single-agent sacituzumab govitecan, a trophoblast cell-surface antig
Autor:
Angela Lamarca, Teresa Macarulla, Do Youn Oh, Ghassan K. Abou-Alfa, Ivan Borbath, Sameek Roychowdhury, Milind Javle, Amit Pande, Shalini Makawita, Allen Cohn, Lipika Goyal, Terry Cho, Rachna T. Shroff, Michael Howland, Saeed Sadeghi, Ai Li
Publikováno v:
Future Oncology. 16:2375-2384
Cholangiocarcinoma is an aggressive malignancy with poor overall survival. Approximately 15% of intrahepatic cholangiocarcinomas contain FGFR alterations. Infigratinib is an oral FGFR 1–3 kinase inhibitor. Favorable results from a Phase II trial of
Publikováno v:
Journal of Geoscience Education. 67:320-329
Poor gender, ethnic, and racial diversity in the geosciences and most of STEM indicates that current approaches to facilitating inclusion and equity are not complete. The prevailing academic cultur...
Autor:
Shalini, Makawita, Ghassan, K Abou-Alfa, Sameek, Roychowdhury, Saeed, Sadeghi, Ivan, Borbath, Lipika, Goyal, Allen, Cohn, Angela, Lamarca, Do-Youn, Oh, Teresa, Macarulla, Rachna, T Shroff, Michael, Howland, Ai, Li, Terry, Cho, Amit, Pande, Milind, Javle
Publikováno v:
Future oncology (London, England). 16(30)
Cholangiocarcinoma is an aggressive malignancy with poor overall survival. Approximately 15% of intrahepatic cholangiocarcinomas contain